Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
JPMA-Journal of Pakistan Medical Association. 2015; 65 (2): 148-152
in English | IMEMR | ID: emr-153753

ABSTRACT

To determine treatment efficacy of curettage on endometrial polyp. The quasi-experimental pre-and-post study was conducted in 2011-12 at the gynaecology department of Imam Reza Hospital, Mashhad, Iran, and comprised patients who underwent hysteroscopy for endometrial polyp. Location, size, number and base condition of the polyps were recorded before the patient underwent curettage. Hysteroscopy was then performed and the condition of the remaining polyps was compared with initial findings. Also, the remaining polyps were resected. SPSS 13 was used for statistical analysis. There were 51 patients in the study with a mean age of 33.14 +/- 8.19 years [range: 23-59 years]. Besides, there were 82 polyps; 38[46.3%] having a narrow base, and 44[53.7%] having a wide base. The mean polyp size was 2.39 +/- 2.63cm.After performing curettage, 23[28.0%] polyps were removed completely, 39[47.6%] had size reduction, and 20[24.4%] had no change in size. Curettage could not significantly remove polyps [p<0.001].Polyps smaller than 2cm were more likely to have been removed compared to the bigger ones [p=0.003].Polyps with wide base were more significantly removed than those with narrow base [p<0.001].Further, those with wide base and also smaller than 2cm were removed more significantly than others [p<0.001].The location of polyps had no effect on removal probability by curettage [p=0.114]. Curettage was not found to be a reliable method for endometrial polyp removal. If hysteroscopy is not accessible, the size of the polyp should be determined by vaginal sonograghy to estimate the probability of its removal by curettage


Subject(s)
Humans , Female , Polyps/surgery , Curettage , Hysteroscopy
2.
IJFS-International Journal of Fertility and Sterility. 2015; 9 (1): 17-26
in English | IMEMR | ID: emr-161837

ABSTRACT

There are still many questions about the ideal protocol for letrozole [LTZ] as the commonest aromatase inhibitor [AI] used in ovulation induction. The aim of this study is to compare the ultrasonographic and hormonal characteristics of two different initiation times of LTZ in clomiphene citrate [CC] failure patients and to study androgen dynamics during the cycle. This randomized clinical trial was done from March to November 2010 at the Mashhad IVF Center, a university based IVF center. Seventy infertile polycystic ovarian syndrome [PCOS] patients who were refractory to at least 3 CC treatment cycles were randomly divided into two groups. Group A [n=35] receiving 5 mg LTZ on cycle days 3-7 [CD3], and group B [n=35] receiving the same amount on cycle days 5-9 [CD5]. Hormonal profile and ultrasonographic scanning were done on cycle day 3 and three days after completion of LTZ treatment [cycle day 10 or 12]. Afterward, 5,000-10,000 IU human chorionic gonadotropin [hCG] was injected if at least one follicle >/= 18 mm was seen in ultrasonographic scanning. Intrauterine insemination [IUI] has been done 36-40 hours later. The cycle characteristics, the ovulation and pregnancy rate were compared between two groups. The statistical analysis was done using Fisher's exact test, t test, logistic regression, and Mann-Whitney U test. There were no significant differences between two groups considering patient characteristics. The ovulation rate [48.6 vs. 32.4% in group A and B, respectively], the endometrial thickness, the number of mature follicles, and length of follicular phase were not significantly different between the two groups. LTZ is an effective treatment in CC failure PCOS patients. There are no significant differences regarding ovulation and pregnancy rates between two different protocols of LTZ starting on days 3 and 5 of menstrual cycle


Subject(s)
Humans , Female , Nitriles , Triazoles , Clomiphene , Menstrual Cycle , Insemination
3.
Cell Journal [Yakhteh]. 2014; 15 (4): 310-315
in English | IMEMR | ID: emr-130704

ABSTRACT

The effects of exposure to electromagnetic fields [EMF] on reproduction systems have been widely debated. In this study, we aimed to investigate whether low frequency EMF could ameliorate the in vitro fertilization success rate in Naval medical research institute [NMRI] Mice. In this randomized comparative animal study, ten NMRI mice were randomly divided into 2 equal groups [control and experimental].10 IU of human chorionic gonadotropin [hCG] was injected intraperitoneally to both groups in order to stimulate ovulating, and ovums were then aspirated and kept in KSOM [modified version of sequential simplex optimization medium with a higher K+ concentration] culture medium. Metaphase II ovums were separated, and sperms obtained by "swim out" method were added to metaphase II ovums in the culture medium. The experimental group was exposed to 1.3 millitesla pulsed electromagnetic field at 4 kilohertz frequency for 5 hours. To assess the efficacy, we considered the identification of two-pronuclear zygote [2PN] under microscope as fertilizing criterion. Total number of collected ovums in the control and experimental groups was 191 and 173, respectively, from which 58 [30.05%] and 52 [30.36%] ovums were collected from metaphase II, respectively. In vitro fertilization [IVF] success rate was 77% in extremely low frequency- pulsed electromagnetic field [ELF-PEMF] for exposed group [experimental], whereas the rate was 68% for control group. Despite increased percentile of IVF success rate in exposed group, there was no statistically significant difference between 2 groups, but this hypothesis has still been stated as a question. Further studies with larger sample sizes and different EMF designs are suggested


Subject(s)
Male , Female , Animals, Laboratory , Electromagnetic Fields , Mice
4.
IJPR-Iranian Journal of Pharmaceutical Research. 2013; 12 (2): 475-481
in English | IMEMR | ID: emr-142670

ABSTRACT

PCOS [Polycystic Ovarian Syndrome] is associated with insulin resistance, obesity and disorders of lipid metabolism as well as infertility. Fenugreek seeds extract is successfully used in lowering blood glucose. Metformin has also the same effect but in a different way. The aim of this study was the assessment of fenugreek effects on insulin resistance in women with PCOS. This was a prospective randomized, double-blind, placebo-controlled trial. The study was conducted at the Montaserieh Hospital in Mashhad University of Medical Sciences, Mashhad, Khorasan Razavi Province, Iran. The patient population included 58 oligo-anovulatory PCOS women with typical ovaries. Women were randomly allocated to receive hydroalcoholic extract of fenugreek seeds in capsules with metformin [n = 30] or placebo capsules with metformin [n = 28] and were assessed before and every 4 weeks within a treatment period of 8 weeks. Menstrual disturbance and metabolic parameters [markers of insulin resistance and hormonal parameters] were measured. Insulin resistance based on HOMA-IR [homeostasis model assessment for insulin resistance] model was not significantly different between two groups. Ultrasound scans were performed before and at the end of 8 weeks treatment with significant decrease in PAO [polycystic appearing ovaries] in group 1 [p = 0/01]. Adjuvant therapy to the fenugreek seeds extract [with metformin] in PCOS women improved the sonographic results and menstrual cyclicity


Subject(s)
Humans , Female , Polycystic Ovary Syndrome/drug therapy , Insulin Resistance , Diabetes Mellitus, Type 2/drug therapy , Blood Glucose/drug effects , Plant Extracts , Phytotherapy/methods , Treatment Outcome , Prospective Studies , Double-Blind Method
SELECTION OF CITATIONS
SEARCH DETAIL